Emerging Influenza Strains in the Last Two Decades: A Threat of a New Pandemic?
暂无分享,去创建一个
E. Montomoli | S. Piccirella | O. Kistner | C. Trombetta | Claudia Trombetta | Simona Piccirella | Daniele Perini | Otfried Kistner | Emanuele Montomoli | D. Perini
[1] Wenjun Song,et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome , 2013, The Lancet.
[2] Y. Guan,et al. Genetic tuning of the novel avian influenza A(H7N9) virus during interspecies transmission, China, 2013. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[3] R. Cox,et al. An H7N1 Influenza Virus Vaccine Induces Broadly Reactive Antibody Responses against H7N9 in Humans , 2014, Clinical and Vaccine Immunology.
[4] R. Cox,et al. A cell‐based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models , 2009, Influenza and other respiratory viruses.
[5] M. Peiris,et al. Human infection with influenza H9N2 , 1999, The Lancet.
[6] A. Monto,et al. Vaccines and Antiviral Drugs in Pandemic Preparedness , 2006, Emerging infectious diseases.
[7] Joel Kelso,et al. Strategies for mitigating an influenza pandemic with pre-pandemic H5N1 vaccines , 2010, Journal of The Royal Society Interface.
[8] British Columbia,et al. Human Illness from Avian Influenza H7N3 , 2004 .
[9] Jiankang Han,et al. Persistent detection of avian influenza A/H7N9 virus among poultry in Huzhou City, China, in the summer of 2013. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[10] J. Makkoch,et al. Global alert to avian influenza virus infection: From H5N1 to H7N9 , 2013, Pathogens and global health.
[11] Jun Yu Li,et al. Limited human-to-human transmission of avian influenza A(H7N9) virus, Shanghai, China, March to April 2013. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[12] E. Padlan. The pandemic 2009 (H1N1) swine influenza virus is mild compared to the pandemic 1918 (H1N1) virus because of a proline-to-serine substitution in the receptor-binding site of its hemagglutinin - a hypothesis. , 2010, Medical hypotheses.
[13] D. Bernstein,et al. Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial. , 2014, JAMA.
[14] K. Neuzil,et al. Assessment of Human Immune Responses to H7 Avian Influenza Virus of Pandemic Potential: Results from a Placebo–Controlled, Randomized Double–Blind Phase I Study of Live Attenuated H7N3 Influenza Vaccine , 2014, PloS one.
[15] P. N. Barrett,et al. Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults , 2014, Clinical and Vaccine Immunology.
[16] I. Donatelli,et al. Influenza surveillance in birds in Italian wetlands (1992-1998): is there a host restricted circulation of influenza viruses in sympatric ducks and coots? , 2004, Veterinary microbiology.
[17] Y. Guan,et al. H9N2 Influenza Viruses Possessing H5N1-Like Internal Genomes Continue To Circulate in Poultry in Southeastern China , 2000, Journal of Virology.
[18] K. Subbarao,et al. Development of a High-Yield Live Attenuated H7N9 Influenza Virus Vaccine That Provides Protection against Homologous and Heterologous H7 Wild-Type Viruses in Ferrets , 2014, Journal of Virology.
[19] P. Horby,et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. , 2012, The Lancet. Infectious diseases.
[20] J. Treanor. Expanding the options for confronting pandemic influenza. , 2014, JAMA.
[21] W. Keitel,et al. Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial. , 2010, Vaccine.
[22] J. Noh,et al. Immunogenicity and Safety of the Influenza A/H1N1 2009 Inactivated Split-Virus Vaccine in Young and Older Adults: MF59-Adjuvanted Vaccine versus Nonadjuvanted Vaccine , 2011, Clinical and Vaccine Immunology.
[23] I. Donatelli,et al. A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine. , 2009, Vaccine.
[24] G. Gao,et al. H7N9: a low pathogenic avian influenza A virus infecting humans , 2014, Current Opinion in Virology.
[25] R. Brunham,et al. Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, Canada , 2006, Canadian Medical Association Journal.
[26] Fabrice Carrat,et al. Transmissibility and geographic spread of the 1889 influenza pandemic , 2010, Proceedings of the National Academy of Sciences.
[27] Libo Dong,et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. , 2009, The New England journal of medicine.
[28] C. Hohenadl,et al. Immunogenicity and Protective Efficacy of a Vero Cell Culture-Derived Whole-Virus H7N9 Vaccine in Mice and Guinea Pigs , 2015, PloS one.
[29] V. Cheng,et al. Emergence in China of human disease due to avian influenza A(H10N8)--cause for concern? , 2014, The Journal of infection.
[30] J. Tam,et al. Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011. , 2011, Vaccine.
[31] P. Palese,et al. Unraveling the Mystery of Swine Influenza Virus , 2009, Cell.
[32] S. Lal,et al. H7N9: A killer in the making or a false alarm? , 2014, Canadian journal of microbiology.
[33] A. García-Sastre,et al. A Reassortment-Incompetent Live Attenuated Influenza Virus Vaccine for Protection against Pandemic Virus Strains , 2011, Journal of Virology.
[34] Miquel Porta,et al. A Dictionary of Epidemiology , 2008 .
[35] Jinquan Cheng,et al. Seroprevalence to avian influenza A(H7N9) virus among poultry workers and the general population in southern China: a longitudinal study. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[36] R. Webster,et al. Replication of avian influenza viruses in humans , 2005, Archives of Virology.
[37] R. Webster,et al. A single dose of whole inactivated H7N9 influenza vaccine confers protection from severe disease but not infection in ferrets. , 2014, Vaccine.
[38] A. Osterhaus,et al. Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control , 2009, Human vaccines.
[39] Ron A M Fouchier,et al. Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans , 2009, Science.
[40] Tatsuya Nishi,et al. Potency of an inactivated influenza vaccine prepared from A/duck/Mongolia/119/2008 (H7N9) against the challenge with A/Anhui/1/2013 (H7N9). , 2014, Vaccine.
[41] Jie Dong,et al. Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus. , 2018 .
[42] A. García-Sastre,et al. Avian influenza A H10N8—a virus on the verge? , 2014, The Lancet.
[43] W. Keitel,et al. Influenza A(H5N1) Vaccines: Are We Better Prepared for the Next Pandemic? , 2013, The Journal of infectious diseases.
[44] L. Rudenko,et al. H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic? , 2014, Expert review of vaccines.
[45] K. Nichol,et al. Vaccines for seasonal and pandemic influenza. , 2006, The Journal of infectious diseases.
[46] R. Compans,et al. Immunity to Pre-1950 H1N1 Influenza Viruses Confers Cross-Protection against the Pandemic Swine-Origin 2009 A (H1N1) Influenza Virus , 2010, The Journal of Immunology.
[47] S. D. de Vlas,et al. Serological reports of human infections of H7 and H9 avian influenza viruses in northern China. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[48] G. Gray,et al. First evidence of H10N8 Avian influenza virus infections among feral dogs in live poultry markets in Guangdong province, China. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[49] G. Leroux-Roels,et al. Safety and immunogenicity of an MF59-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age. , 2015, Vaccine.
[50] N. Cox,et al. Global concerns regarding novel influenza A (H7N9) virus infections. , 2013, The New England journal of medicine.
[51] R. Gasparini,et al. Live attenuated influenza vaccine--a review. , 2011, Journal of preventive medicine and hygiene.
[52] S. Opal,et al. The controversy over H5N1 transmissibility research , 2013, Human vaccines & immunotherapeutics.
[53] H. Jin,et al. Development of live attenuated influenza vaccines against pandemic influenza strains , 2014, Expert review of vaccines.
[54] G. Milne,et al. Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis , 2013, BMC Infectious Diseases.
[55] Weizhong Yang,et al. Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study , 2014, The Lancet.
[56] T. Popović,et al. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. , 2009, MMWR. Morbidity and mortality weekly report.
[57] E. Faerstein,et al. A DICTIONARY OF EPIDEMIOLOGY , 2016 .
[58] L. Rudenko,et al. Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus , 2015, Expert review of vaccines.
[59] Marion Koopmans,et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[60] Keiji Fukuda,et al. Detection of Antibody to Avian Influenza A (H5N1) Virus in Human Serum by Using a Combination of Serologic Assays , 1999, Journal of Clinical Microbiology.
[61] G. Air,et al. Evaluations for In Vitro Correlates of Immunogenicity of Inactivated Influenza A H5, H7 and H9 Vaccines in Humans , 2012, PloS one.
[62] Ming Wang,et al. Antibodies against H5 and H9 avian influenza among poultry workers in China. , 2009, The New England journal of medicine.
[63] R. Walker,et al. Live attenuated versus inactivated influenza vaccine in infants and young children. , 2007, The New England journal of medicine.
[64] L. Rudenko,et al. H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus. , 2013, Vaccine.
[65] B. Kumar,et al. Emerging influenza virus: A global threat , 2008, Journal of Biosciences.
[66] H. Fineberg. Pandemic preparedness and response--lessons from the H1N1 influenza of 2009. , 2014, The New England journal of medicine.
[67] C. Hohenadl,et al. A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate. , 2012, Vaccine.
[68] R. Gao,et al. Genesis of the novel human-infecting influenza A(H10N8) virus and potential genetic diversity of the virus in poultry, China. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[69] Ke Xu,et al. Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation , 2013, BMJ.
[70] E. Montomoli,et al. Is influenza A/H10N8 a potential candidate for the next pandemic? , 2014, Pathogens and global health.
[71] G. Gao,et al. Continuous reassortments with local chicken H9N2 virus underlie the human-infecting influenza A (H7N9) virus in the new influenza season, Guangdong, China , 2014, Protein & Cell.
[72] J. Chan,et al. The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities , 2013, The Lancet Infectious Diseases.
[73] Y. Guan,et al. Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong? , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[74] Martin Hirst,et al. Human Illness from Avian Influenza H7N3, British Columbia , 2004, Emerging infectious diseases.
[75] Yi Guan,et al. Human Infection with an Avian H9N2 Influenza A Virus in Hong Kong in 2003 , 2005, Journal of Clinical Microbiology.
[76] X. Kan,et al. Origin and molecular characteristics of a novel 2013 avian influenza A(H6N1) virus causing human infection in Taiwan. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[77] P. Dormitzer,et al. A Cell Culture–Derived MF59-Adjuvanted Pandemic A/H7N9 Vaccine Is Immunogenic in Adults , 2014, Science Translational Medicine.
[78] C. Ambrose,et al. Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza , 2008, Influenza and other respiratory viruses.
[79] E. Lau,et al. Preliminary inferences on the age-specific seriousness of human disease caused by avian influenza A(H7N9) infections in China, March to April 2013. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[80] R. Webster,et al. H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity. , 2001, Virology.
[81] B. Ligon,et al. Avian influenza virus H5N1: a review of its history and information regarding its potential to cause the next pandemic. , 2005, Seminars in pediatric infectious diseases.
[82] R. Jacobson,et al. Avian and pandemic influenza: an overview. , 2007, Vaccine.
[83] Ching-Yuan Chang,et al. Squalene-adjuvanted H7N9 virus vaccine induces robust humoral immune response against H7N9 and H7N7 viruses. , 2014, Vaccine.
[84] S. Inglis,et al. Prospects for controlling future pandemics of influenza. , 2011, Virus research.
[85] T. Tumpey,et al. Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility , 2008, Proceedings of the National Academy of Sciences.
[86] Thomas D Szucs,et al. Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans. , 2008, The Lancet. Infectious diseases.
[87] H. Liu,et al. Transmission of avian influenza A(H7N9) virus from father to child: a report of limited person-to-person transmission, Guangzhou, China, January 2014. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[88] S. Vong. Editorial commentary: some perspectives regarding risk factors for a(H7N9) influenza virus infection in humans. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.